USA Today: Why volunteer for a vaccine clinical trial? Duty, love and a willingness to experiment, participants say
First patient dosed in UC/UC Health vaccine trial says his son was a major motivation to volunteer
In a story about people who volunteer for COVID-19 vaccine trials, USA Today featured Jarelle Marshall, a 37-year-old IT professional from Cincinnati. He was the first patient to be dosed as part of the UC and UC Health trial of the Moderna COVID-19 vaccine trial.
A UC pharmacist prepares a dose for the COVID-19 vaccine trial. Photo/Colleen Kelley/UC Creative + Brand
Marshall said his 14-year-old son was a big part of his motivation to volunteer. "I always tell my son that what matters is what you do when people aren't looking," he said.
That's why when a friend asked him to participate in the trial, he didn't hesitate long. First, he asked for more information, which he forwarded to another friend, a doctor, to ask for advice. The doctor sent him a long text, telling him what to expect in the trial and why volunteers were important. Then came the kicker: Researchers need African-Americans like you.
Read the entire article here, and read more about the UC/UC Health COVID-19 vaccine trial here.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Local 12: Head injury survivor, doctor share importance of...
April 23, 2024
Local 12 spoke with patient Shane Shapiro and the University of Cincinnati's Laura Ngwenya about the importance of wearing a helmet following Shapiro's traumatic brain injury and recovery.
WVXU: Why is part of Green Township called Dent?
April 23, 2024
UC College of Arts and Sciences professor tells WVXU that Ohio's glacial past might explain how Dent got its name.
WVXU: Find your CPAP annoying? UC researchers are working on a...
April 22, 2024
Dr. Liran Oren is leading a research team at the University of Cincinnati developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.